IDEAYA Biosciences ( NASDAQ:IDYA ) First Quarter 2024 Results Key Financial Results Net loss: US$39.6m (loss widened by...
Comparative Analysis of Q1 Earnings Against Analyst Expectations and Future Projections
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update, and announced financial results for the first quarter ended March 31, 2024.